Latest News for: engrailed

Edit

Engrail Therapeutics Initiates ENX-104 Clinical Program for the Treatment of Major Depressive ...

Hastings Tribune 18 Sep 2024
The first-in-human Phase 1 clinical study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamic profile of ENX-104 in healthy volunteers ... .
Edit

Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the Development of Transformational Therapies (ASEBIO - Asociación Española de Bioempresas)

Public Technologies 20 Mar 2024
Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the Development of Transformational Therapies. Ysios Capital participates in the financing round for the capital increase of the US company Engrail Therapeutics.
Edit

Neuroscience firm Engrail bags $157M Series B funding for clinical development of therapies

Your Story 19 Mar 2024
Founded in 2019, US-based Engrail Therapeutics offers solutions to patients with neuropsychiatric and neurodevelopment diseases ....
Edit

Engrail raises $157 million in Series-B round of funding

Live Mint 19 Mar 2024
Medicine for anxiety and depression without any of the known side effects of the currently available therapies—that's the promise upon which Engrail Therapeutics has raised $157 million of venture ...
Edit

Engrail Therapeutics Initiates the ENCALM Phase 2 Clinical Trial of ENX-102 in Patients with Generalized ...

Business Wire 18 Jul 2023
SAN DIEGO--(BUSINESS WIRE)--Engrail Therapeutics™ (Engrail) (the Company), a precision neuroscience ...
Edit

Engrail Therapeutics Initiates the ENCALM Phase 2 Clinical Trial of ENX-102 in Patients with Generalized Anxiety Disorder

Pharmiweb 18 Jul 2023
SAN DIEGO--(BUSINESS WIRE)--Engrail Therapeutics™ (Engrail) (the Company), a precision neuroscience company focused on the acquisition, development, and commercialization of transformational ...
  • 1

Most Viewed

×